-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Reata Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2023.
- Reata Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $13.1M, a 6643% increase year-over-year.
- Reata Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.49M, a 83.7% decline from 2021.
- Reata Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $9.14M, a 98.1% decline from 2020.
- Reata Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $477M, a 17.8% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)